Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02811549 · ClinicalTrials.gov registry record · NA

Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss

A NA study of Hearing Loss and Hearing Disorders, sponsored by Advanced Bionics.

Completed
Registry status
NA
Development phase
24
Enrollment target
2
Study locations

NCT02811549 is a NA study of Hearing Loss and Hearing Disorders that has completed, run by Advanced Bionics. The registered enrollment target is 24 participants, below the 6,121-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02811549, a NA study of Hearing Loss and Hearing Disorders, has completed, sponsored by Advanced Bionics.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this feasibility study is to evaluate the benefit of unilateral implantation in adults who have severe to profound sensorineural hearing loss in one ear, and up to moderate sensorineural hearing loss in the other ear (asymmetric hearing loss).

Interventions

  • DEVICE HiResolution Bionic Cochlear Implant

Study Locations (2)

Florida

  • The Silverstein Institute - Sarasota

Washington

  • Virginia Mason Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2016-11-07
Est. Completion 2020-03-25
Phase NA

Sponsor

Advanced Bionics

8 total trials

What the Registry Record Tells You About NCT02811549

The ClinicalTrials.gov registry entry for NCT02811549 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,121-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower). The listed sponsor is Advanced Bionics, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which HiResolution Bionic Cochlear Implant is the first listed.

NCT02811549 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Washington.

Frequently Asked Questions

What is clinical trial NCT02811549 about?

NCT02811549 is a clinical study titled "Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss". The purpose of this feasibility study is to evaluate the benefit of unilateral implantation in adults who have severe to profound sensorineural hearing loss in one ear, and up to moderate sensorineural hearing loss in the other ear (asymmetric hearing loss).

What is the current status of trial NCT02811549?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2016-11-07. Estimated completion is 2020-03-25.

What conditions does trial NCT02811549 study?

This clinical trial studies the following conditions: Hearing Loss, Hearing Disorders, Single Sided Deafness, Ear Diseases, Otorhinolaryngologic Diseases.

What interventions are being tested in trial NCT02811549?

The interventions under investigation include: HiResolution Bionic Cochlear Implant (DEVICE).

Who is sponsoring clinical trial NCT02811549?

This trial is sponsored by Advanced Bionics, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02811549 being conducted?

This trial has 2 study locations across Florida, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.